Evidence map›Paper›PMID 29855634›Full record

ArticleThrombosis journal2018

Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.

Alexander T Cohen, Cihan Ay, Philippe Hainaut, Hervé Décousus, Ulrich Hoffmann, Sean Gaine, Michiel Coppens, Pedro Marques da Silva, David Jimenez, Beatrice Amann-Vesti and 11 more

Abstract readPublished Erratum
In one paragraph

Article in Thrombosis journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Alexander T Cohen1Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Cihan Ay2Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Philippe Hainaut3Department of General Internal Medicine, Cliniques Universitaires Saint Luc, UCL, Bruxelles, Belgium.
Hervé Décousus4Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest En Jarez, France.
Ulrich HoffmannDivision of Angiology, Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Sean Gaine6National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Michiel Coppens7Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Pedro Marques da Silva8Department of Internal Medicine, Arterial Investigation Unit, Hospital de Santa Marta, Lisbon, Portugal.
David Jimenez9Respiratory Department, Ramón y Cajal Hospital, Madrid, Spain.
Beatrice Amann-Vesti10Division of Angiology, University Hospital Zurich, Zurich, Switzerland.
Bernd Brüggenjürgen11Institute for Health Economics, Steinbeis-University, Berlin, Germany.
Pierre Levy12LEGOS, Université Paris - Dauphine, Paris, France.
Julio Lopez Bastida13University of Castilla-La Mancha, Talavera de la Reina, Toledo Spain.
Eric Vicaut14Department of Medicine, Université Paris Descartes, Paris, France.
Petra Laeis15Daiichi Sankyo Europe GmbH, Munich, Germany.
Eva-Maria Fronk15Daiichi Sankyo Europe GmbH, Munich, Germany.
Wolfgang Zierhut15Daiichi Sankyo Europe GmbH, Munich, Germany.
Thomas Malzer15Daiichi Sankyo Europe GmbH, Munich, Germany.
Peter BramlageInstitute for Pharmacology and Preventive Medicine, Berlin, Germany.
Giancarlo Agnelli17Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
ETNA-VTE-Europe investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1186/s12959-018-0163-7.].

Identifiers

PMID29855634
PMCPMC5977454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.